| Sanchez, Eduardo Vilar |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome |
5R01CA260761-04 |
|
Asad Umar, D.V.M., Ph.D. |
| Infante, Rodney E |
Ut Southwestern Medical Center
United States |
Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia |
3R01CA266900-04S1 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Marjorie Perloff, M.D. |
| Majumder, Shounak |
Mayo Clinic Rochester
United States |
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer |
5U01CA210138-09 |
|
Matthew Young, Ph.D. |
| Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center |
5U54CA272686-04 |
|
John Clifford, Ph.D. |
| Cocucci, Emanuele |
Ohio State University
United States |
A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL |
5R01CA270251-04 |
PAR-20-053 (R01 Clinical Trial Not Allowed) |
Matthew Young, Ph.D. |
| Demb, Joshua Brian |
University Of California, San Diego
United States |
Optimal early colorectal cancer screening initiation |
5R00CA267181-04 |
|
Claire Zhu, Ph.D. |
| Segal, Leopoldo Nicolas |
New York University School Of Medicine
United States |
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer |
5U2CCA271890-03 |
|
Guillermo Marquez, Ph.D. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs |
5U2CCA271895-03 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Schroeck, Florian R |
Veterans Education/Res/Assn/North/Ne
United States |
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance |
5R37CA275916-03 |
|
Claire Zhu, Ph.D. |
| Ghosh, Jayashri |
Temple Univ Of The Commonwealth
United States |
Development of blood-based methylation biomarkers for CRC risk prediction |
5R01CA281948-03 |
|
Matthew Young, Ph.D. |
